SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Abuckatatime who wrote (10484)10/31/1997 8:40:00 AM
From: Henry Niman  Respond to of 32384
 
Greg, Thanks for the heads-up. Here's the abstract for the aging article:
The Endocrinology of Aging

Steven W. J. Lamberts, * Annewieke W. van den Beld, Aart-Jan van der Lely

Most aging individuals die from atherosclerosis, cancer, or dementia; but in the oldest old, loss of
muscle strength resulting in frailty is the limiting factor for an individual's chances of living an
independent life until death. Three hormonal systems show decreasing circulating hormone
concentrations during normal aging: (i) estrogen (in menopause) and testosterone (in andropause), (ii)
dehydroepiandrosterone and its sulphate (in adrenopause), and (iii) the growth hormone/insulin-like
growth factor I axis (in somatopause). Physical changes during aging have been considered
physiologic, but there is evidence that some of these changes are related to this decline in hormonal
activity. Hormone replacement strategies have been developed, but many of their aspects remain
controversial, and increasing blood hormone levels in aging individuals to those found during
mid-adult life has not been uniformly proven to be safe and of benefit.

The authors are in the Department of Medicine, Erasmus University, Rotterdam, Netherlands.
* To whom correspondence should be addressed at the Department of Medicine, University
Hospital Dijkzigt, 40 Dr. Molewaterplein, 3015 GD Rotterdam, Netherlands. E-mail:
lamberts@inw3.azr.nl